Konstantin Konstantinov - 28 Mar 2023 Form 4 Insider Report for Codiak BioSciences, Inc.

Role
Chief Technology Officer
Signature
/s/ Yalonda Howze, Attorney-in-Fact for Konstantin Konstantinov
Issuer symbol
N/A
Transactions as of
28 Mar 2023
Net transactions value
-$1,874
Form type
4
Filing time
30 Mar 2023, 17:13:35 UTC
Previous filing
26 Jan 2023
Next filing
22 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDAKQ Common Stock Sale $1,487 -7,432 -79% $0.2001* 1,932 28 Mar 2023 Direct F1
transaction CDAKQ Common Stock Sale $386 -1,932 -100% $0.2000* 0 28 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 1,932 shares of common stock acquired on June 30, 2022 and December 30, 2022 under the Issuer's Employee Stock Purchase Plan (ESPP).